RESUMEN
OBJECTIVE: To assess the effect of the lipidosterolic extract of Serenoa repens (LSESr) on in vitro cell proliferation in biopsies of human prostate MATERIAL AND METHODS: Cell proliferation was assessed by incorporation of [3H]thymidine followed by historadiography. RESULTS: Basic fibroblast growth factor (b-FGF) induced a considerable increase in human prostate cell proliferation (from +100 to +250%); the glandular epithelium was mainly affected, minimal labeling being recorded in the other regions of the prostate. Similar results were observed with epidermal growth factor (EGF), although the increase in cell proliferation was not recorded in some cases. Lovastatin, an inhibitor of hydroxymethylglutaryl coenzyme A, antagonized both the basal proliferation and the growth factor-stimulated proliferation of human prostate epithelium (EGF, mean inhibition approximately 80-95%; b-FGF, mean inhibition approximately 40-90%). Geraniol, a precursor of both farnesyl pyrophosphate and geranylgeranyl pyrophosphate, and farnesol, the precursor of farnesyl pyrophosphate, increased cell proliferation only in some prostate specimens, this effect being antagonized by lovastatin. LSESr did not affect basal prostate cell proliferation, with the exception of two prostate specimens in which a significant inhibition of basal proliferation was observed with the highest concentration of LSESr (30 micrograms/ ml). In contrast, LSESr inhibited b-FGF-induced proliferation of human prostate cell cultures; this effect was significant for the highest concentration of LSESr (30 micrograms/ml). In some prostate samples, a similar inhibition was also noted with lower concentrations. Unsaturated fatty acids (UFA), in the range 1-30 ng/ml), did not affect the basal prostate cell proliferation, only a slight increase in cell proliferation was noted in 1 prostate specimen. UFA (1, 10 or 30 micrograms/ml) markedly inhibited the b-FGF-induced cell proliferation down to the basal value. Lupenone, hexacosanol and the unsaponified fraction of LSESr markedly inhibited the b-FGF-induced cell proliferation, whereas a minimal effect on basal cell proliferation was noted. CONCLUSIONS: Despite the large variability in the response of the prostate samples to b-FGF, these results indicate that LSESr and its components affect the proliferative response of prostate cells to b-FGF more than their basal proliferation.
Asunto(s)
Antagonistas de Andrógenos/farmacología , Factor 2 de Crecimiento de Fibroblastos/farmacología , Extractos Vegetales/farmacología , Próstata/efectos de los fármacos , Monoterpenos Acíclicos , División Celular/efectos de los fármacos , Células Cultivadas , Factor de Crecimiento Epidérmico/farmacología , Farnesol/farmacología , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Lovastatina/farmacología , Masculino , Extractos Vegetales/química , Próstata/patología , Hiperplasia Prostática/patología , Serenoa , Terpenos/farmacologíaRESUMEN
Although the lipidic extract of Serenoa repens (LESSr, Permixon, Sereprostat) is widely used in patients suffering from benign prostatic hypertrophy (BPH), its mechanism of action is not fully elucidated. It has been demonstrated that infiltration of the prostate by inflammatory cells is one of the aetiologic factors involved in the development of BPH. These inflammatory cell types, such as polymorphonuclear neutrophils (PMNs), produce chemotactic mediators and contribute to the development of the disease. Among the chemotactic factors generated by inflammatory cell types, the derivatives of arachidonic acid have been extensively studied. For instance, leukotriene (LT) B4 is one of the most potent chemotactic factors for PMNs and also exhibits a wide range of biological activities. In order to investigate the potential action of LESSr on arachidonate metabolism, and particularly on the synthesis of LTB4, the effect of this extract on the in vitro synthesis of LT by human PMNs stimulated with the calcium ionophore A23187 was investigated. LESSr significantly inhibits the production of 5-lipoxygenase metabolites (5-HETE, 20-COOH LTB4, LTB4 and 20-OH LTB4) at concentrations as low as 5 microg/ml. Such an effect of LESSr was also observed in the presence of exogenous arachidonic acid (20 microg/ml) and when f-MLP was used as the agonist, suggesting that inhibition of LTB4 production by the extract was unrelated to phospholipase A2 blockade and independent of the stimulating agent. The capability of LESSr to antagonize 5-lipoxygenase metabolites production may contribute, at least partly, to the understanding of its therapeutic activity on the inflammatory component of BPH.
Asunto(s)
Calcimicina/farmacología , Ionóforos/farmacología , Leucotrieno B4/biosíntesis , Neutrófilos/metabolismo , Extractos Vegetales/farmacología , Araquidonato 5-Lipooxigenasa/metabolismo , Supervivencia Celular , Humanos , Masculino , N-Formilmetionina Leucil-Fenilalanina/farmacología , Neutrófilos/efectos de los fármacos , Hiperplasia Prostática/tratamiento farmacológico , SerenoaRESUMEN
This study was undertaken to evaluate whether the renal damage induced by cold ischemia-reperfusion was worsened by neutrophils (PMN), and if blockade of platelet-activating factor (PAF) could effectively decrease this injury. After flushing with EuroCollins, 85 kidneys from Sprague-Dawley rats underwent either no cold ischemia or a 4-h cold ischemia, and then were reperfused for 75 min at 37 degrees C and 100 mm Hg in an isolated perfusion circuit. Reperfusion was performed with a Krebs-Henseleit solution containing 4.5% albumin, with and without human PMN (7.5 x 10(5) cells/ml) and with and without addition of a PAF receptor antagonist (BN 52021). Hemodynamic and functional parameters were continuously assessed during reperfusion. At end of the study, PAF production was evaluated. Presence of PMN during reperfusion of nonischemic kidneys produced no alteration of functional parameters or PAF production. After 4-h cold ischemia, the presence of PMN during reperfusion produced a significant worsening of plasma flow rate, glomerular filtration rate and sodium reabsorption in comparison with kidneys reperfused without PMN. Also, higher production of PAF was observed in the kidneys reperfused with PMN than in the kidneys reperfused without PMN. After 4-h cold ischemia, addition of BN 52021 during reperfusion in the presence of PMN significantly increased the plasma flow rate, glomerular filtration rate and sodium reabsorption in comparison with kidneys reperfused without this PAF antagonist. This effect was dose dependent. After 4-h cold ischemia, addition of BN 52021 during reperfusion in the absence of PMN produced no significant effect on functional parameters in comparison with kidneys reperfused without this PAF antagonist. These results indicate that PMN contribute to renal cold ischemia-reperfusion injury evaluated in the isolated perfused kidney. Treatment with a PAF receptor antagonist attenuated this injury in a dose-dependent manner, which suggests that it is mediated by PAF.
Asunto(s)
Diterpenos , Riñón/irrigación sanguínea , Lactonas/farmacología , Neutrófilos/fisiología , Factor de Activación Plaquetaria/antagonistas & inhibidores , Daño por Reperfusión/prevención & control , Daño por Reperfusión/fisiopatología , Animales , Frío , Fibrinolíticos/farmacología , Ginkgólidos , Tasa de Filtración Glomerular/efectos de los fármacos , Glucosa , Humanos , Soluciones Hipertónicas , Técnicas In Vitro , Riñón/efectos de los fármacos , Riñón/fisiología , Masculino , Preservación de Órganos , Factor de Activación Plaquetaria/biosíntesis , Ratas , Ratas Sprague-Dawley , Circulación Renal/efectos de los fármacos , Trometamina , Resistencia Vascular/efectos de los fármacosAsunto(s)
División Celular/efectos de los fármacos , Lovastatina/farmacología , Prenilación de Proteína , Animales , Células Cultivadas , ADN/biosíntesis , Replicación del ADN/efectos de los fármacos , Embrión de Mamíferos , Factor 2 de Crecimiento de Fibroblastos/farmacología , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , RatonesRESUMEN
The effect of the lipidosterolic extract of Serenoa repens (LSESR) on experimental prostate enlargement was investigated in three groups of rats: shams treated with LSESR (sham rats), castrated animals treated with estradiol and testosterone (castrated rats), castrated animals treated with estradiol/testosterone and treated with LSESR (castrated and treated rats). Following three months of continuous hormonal treatment, the weight of prostates in estradiol/testosterone-treated castrated rats was significantly increased in comparison with sham-operated rats. Such an increase started rapidly, reached a maximum by 30 days and remained at a plateau or slightly declined thereafter. The increase of prostate total weight induced by the hormone treatment was inhibited by administration of LSESR. Indeed, the weight was significantly lower at day 60 and day 90 for the dorsal and lateral regions of the prostate. The weight of the ventral region of the prostate was significantly lower after 30 and 60 days treatment with LSESR. These results demonstrate that administering LSESR to hormone-treated castrated rats inhibits the increase in prostate wet weight. This effect of LSESR may explain the beneficial effect of this extract in human benign prostatic hypertrophy.
Asunto(s)
Antagonistas de Andrógenos/uso terapéutico , Estradiol , Extractos Vegetales/uso terapéutico , Plantas Medicinales/química , Hiperplasia Prostática/tratamiento farmacológico , Testosterona , Animales , Masculino , Orquiectomía , Tamaño de los Órganos/efectos de los fármacos , Hiperplasia Prostática/inducido químicamente , Hiperplasia Prostática/patología , Ratas , Ratas Wistar , SerenoaRESUMEN
Abnormalities of thiamin metabolism have been reported in senile dementia of Alzheimer's type (SDAT). Transketolases (TK) were studied in 21 patients with SDAT, 24 age-matched controls and 12 chronic alcoholics. Erythrocytes were assessed for their TK activity coefficient (TK-AC, normal value 8.4 +/- 12.6%) and affinity for thaimin pyrophosphate (Km TPP, normal value 17.8 +/- 8.3 mumol). Comparison between study groups and controls demonstrated increased TK-AC in SDAT (16.6 +/- 15.7%, P < 0.05) and chronic alcoholism (43.4 +/- 40.6%, P < 0.05), and increased Km TPP (38.3 +/- 25.2 mumol, P < 0.01) in SDAT only. These findings suggest structural abnormalities of TK rather than vitamin B1 deficiency in SDAT.
Asunto(s)
Enfermedad de Alzheimer/enzimología , Eritrocitos/enzimología , Transcetolasa/metabolismo , Anciano , Anciano de 80 o más Años , Alcoholismo/sangre , Alcoholismo/enzimología , Activación Enzimática , Femenino , Humanos , Masculino , Tiamina Pirofosfato/metabolismoRESUMEN
Pygeum africanum extract has been used for more than 20 years in France in patients suffering from benign prostatic hypertrophy (BPH). The extract displays anti-inflammatory activity and inhibits bladder hyperreactivity during the above conditions. However, the mechanism of action of P. africanum extract has never been clearly resolved. It has been recently demonstrated that infiltration by inflammatory cells may be involved in the development of BPH. Certain of these cell types, such as macrophages, are known to produce chemotactic mediators including leukotrienes, and thus may contribute to the development of the disease. In order to investigate the potential effect of P. africanum extract on arachidonate metabolism, we examined its effect in vitro on leukotriene (LT) synthesis in human polymorphonuclear cells stimulated with the calcium ionophore A23187. Two formulations of the extract were tested, one dissolved in DMSO and one aqueous solution obtained after alkalinization (0.1 N; NaOH/acidification (0.1 N; HCl). Neither formulation had any effect on cell viability which was above 95% in both cases. P. africanum extract dissolved in DMSO significantly inhibited the production of 5-lipoxygenase metabolites (5-HETE, 20-COOH LTB4, LTB4 and 20-OH LTB4) at concentrations as low as 3 micrograms/ml (p < 0.01), while the same extract dissolved in NaOH/HCl only exhibited an inhibitory effect at 10 micrograms/ml (p < 0.01). This difference apparently reflects the greater solubility of the active components in the extract in DMSO. The ability of P. africanum to antagonize 5-lipoxygenase metabolite production may contribute, at least in part, to its therapeutic activity in inflammatory component of BPH.
Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Araquidonato 5-Lipooxigenasa/sangre , Calcimicina/farmacología , Alcoholes Grasos/farmacología , Leucotrienos/biosíntesis , Neutrófilos/efectos de los fármacos , Neutrófilos/enzimología , Extractos Vegetales/farmacología , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Interacciones Farmacológicas , Humanos , Ácido Clorhídrico , Leucotrienos/sangre , Inhibidores de la Lipooxigenasa , Hidróxido de Sodio , Solubilidad , Estimulación QuímicaRESUMEN
The heterogeneous nature of cytotoxic effector cells presents a difficult obstacle to the study of developmental, biochemical and molecular events governing cytotoxic T lymphocytes (CTL) and natural killer (NK) cell biology. In previous studies, there were no available methods, other than the single cell assay or micromanipulation techniques that could distinguish between lytic and non-lytic cells present in purified populations or clones. Further, there were no available means to isolate these subsets for further investigation. The studies presented here describe a novel approach to identify and isolate cells based on their functional characteristics. Thus, non-lytic free and conjugate forming cells as well as killer cells could be identified, quantified, and further purified by flow cytometric cell sorting for further investigations. Studies of several properties of isolated NK subpopulations (free, non-lytic binders, and killers) are presented.
Asunto(s)
Citometría de Flujo/métodos , Células Asesinas Naturales/inmunología , Linfocitos T Citotóxicos/inmunología , Animales , Diferenciación Celular , Separación Celular/métodos , Citotoxicidad Inmunológica , Células Asesinas Naturales/citología , Ratones , Subgrupos de Linfocitos T/citología , Subgrupos de Linfocitos T/inmunología , Linfocitos T Citotóxicos/citologíaRESUMEN
In the present paper, a standardized method for the induction and registration of platelet thrombi in arterioles (500 microns diameter) of small laboratory animals is described in full detail. Using an optoelectronic analogue computer device, different discriminating parameters characteristic for the thrombotic phenomenon are presented. As the topical application of exogenous PAF-acether induces the generation of endogenous PAF-acether according to previous investigations (Bourgain et al. (1985) Prostaglandins 30, 185) it was deemed interesting to investigate the effect of hydrogen peroxide using the described methodology. It was found that the latter substance not only primes the effect of PAF-acether-induced thrombosis, but also can trigger by itself PAF-acether modulated arterial thrombus formation. Experimental evidence is adduced that these thrombotic phenomena can be most efficiently down regulated by specific PAF-acether antagonists.
Asunto(s)
Adenosina Difosfato , Arteriopatías Oclusivas/inducido químicamente , Electrochoque/métodos , Endotelio Vascular/patología , Peróxido de Hidrógeno , Factor de Activación Plaquetaria , Trombosis/inducido químicamente , Animales , Animales de Laboratorio , Arteriopatías Oclusivas/fisiopatología , Arteriolas/efectos de los fármacos , Arteriolas/patología , Cobayas , Técnicas In Vitro , Masculino , Arterias Mesentéricas , Ratas , Ratas Wistar , Trombosis/fisiopatologíaRESUMEN
Guinea-pigs pretreated with phosphoramidon or saline were treated with an aerosol of substance P (SP) or saline. 24 h later, the pulmonary inflation pressure (PIP) to substance P or to cumulative doses of acetylcholine or of histamine was recorded. The PIP response to SP itself was significantly enhanced in animals treated with phosphoramidon+SP as compared with phosphoramidon+saline (2.5-fold increase 1 min after the end of the inhalation, P < 0.001). The response to acetylcholine and to histamine was also significantly enhanced in phosphoramidon+substance P-treated as compared with phosphoramidon+saline-treated guinea-pigs (PC200 = 38.9 and 1.6 as compared with 77.6 and 3.9 micrograms/ml, P < 0.01 and P < 0.05 respectively). The production of superoxide anions by alveolar macrophages in response to f-MLP was also enhanced after treatment with phosphoramidon+SP as compared with phosphoramidon+saline (6.4 +/- 0.7 and 3.8 +/- 0.3 cpm, P < 0.001 respectively). In animals treated with saline+SP or saline+saline, the PIP responses and the production of superoxide anion were similar. Altogether these results suggest that SP contributes to the bronchial hyper-responsiveness in asthma and this probably through activation of alveolar macrophages.
Asunto(s)
Bronquios/efectos de los fármacos , Pulmón/efectos de los fármacos , Macrófagos Alveolares/efectos de los fármacos , Sustancia P/farmacología , Acetilcolina/farmacología , Administración por Inhalación , Animales , Líquido del Lavado Bronquioalveolar/citología , Cobayas , Histamina/farmacología , Mediciones Luminiscentes , Luminol , Masculino , N-Formilmetionina Leucil-Fenilalanina/farmacología , Sustancia P/administración & dosificaciónRESUMEN
Somatostatin is an endogenous cyclic tetradecapeptide which can exert effects on a wide range of gastrointestinal functions, including gastric acid and pepsin secretion, gastric and small intestinal motility, splanchnic blood flow, pancreatic enzyme secretion, intestinal nutrient absorption and gallbladder contractility. Somatostatin has also been shown to reduce the severity of ethanol-induced gastric damage. In this study, we examined the effect of pretreating rats with somatostatin (s.c.) on susceptibility to gastrointestinal damage induced by hemorrhagic shock, stress, platelet-activating factor (PAF), indomethacin or endotoxin. Somatostatin significantly reduced the extent of gastric damage induced by hemorrhagic shock when given at a dose of 20 micrograms/kg or greater (P < 0.05). Somatostatin (20-50 micrograms/kg) also had a dose-dependent protective effect against stress-induced gastric damage. Versus gastric damage induced by intravenous PAF, a dose of 5 micrograms/kg of somatostatin had no effect, while doses of 15-100 micrograms/kg significantly reduced the extent of injury to the stomach. In contrast, somatostatin had no significant effect on gastric or intestinal damage caused by intravenous administration of Salmonella enteritidis endotoxin or by oral administration of indomethacin, despite significantly and dose-dependently (2-10 micrograms/kg) reducing both the volume and titratable acidity of gastric secretion. A protective dose of somatostatin (20 micrograms/kg) had only a small and transient effect on gastric blood flow. The present results demonstrate the effectiveness of somatostatin in protecting the mucosa from injury in a variety of models, and suggest that inhibition of gastric acid secretion is not the sole mechanism underlying these protective effects.
Asunto(s)
Factor de Activación Plaquetaria/toxicidad , Choque Hemorrágico/complicaciones , Somatostatina/uso terapéutico , Gastropatías/etiología , Gastropatías/prevención & control , Estrés Fisiológico/complicaciones , Animales , Endotoxinas , Ácido Gástrico/metabolismo , Mucosa Gástrica/irrigación sanguínea , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/metabolismo , Indometacina/toxicidad , Masculino , Ratas , Ratas Wistar , Flujo Sanguíneo Regional , Estómago/irrigación sanguínea , Gastropatías/inducido químicamenteRESUMEN
The in vitro effect of nifedipine and atenolol, either alone or in combination, on the proliferation and migration of rat aortic smooth muscle cells was investigated. Nifedipine inhibited the replication of arterial myocytes in concentrations ranging between 10 and 100 microM. The inhibition, evaluated as cell number, was dose- and time-dependent with an IC50 of 39 and 34 microM after 48 and 72 h, respectively; the cell doubling time increased with drug concentrations up to 118 h versus 28 h for controls. Atenolol alone failed to reduce arterial myocyte proliferation, and did not influence the effect of nifedipine on cell proliferation. Nifedipine and atenolol alone inhibited in a dose-dependent manner rat aortic myocytes migration induced by fibrinogen as chemotactic agent. When the combination nifedipine-atenolol was investigated, an additive inhibitory effect on cell migration was observed. These results provide in vitro support for a potential effect of this drug association on early steps of atherogenesis.
Asunto(s)
Atenolol/farmacología , Músculo Liso Vascular/efectos de los fármacos , Nifedipino/farmacología , Animales , Aorta Torácica , Recuento de Células , División Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Combinación de Medicamentos , Fibrinógeno/farmacología , Masculino , Mitosis/efectos de los fármacos , Músculo Liso Vascular/citología , Ratas , Ratas Sprague-DawleyRESUMEN
The effect of beta 2-adrenoceptor agonists and interleukin-4 (IL-4) on the CD23 expression on, and release from, the human promonocytic cell line, U 937, was investigated. As assessed by flow cytometry, incubation of U 937 cells in the presence of salbutamol, fenoterol or IL-4 induced a concentration- and time-dependent increase in CD23 expression, that was maximal after 48 hr and followed by a decrease thereafter. In addition, salbutamol potentiated the effect of IL-4, the optimal concentration of the drug being a function of the concentration of this cytokine. This synergy between IL-4 and beta 2-adrenoceptor agonists was also observed for the release of the soluble form of CD23. The effect on CD23 expression of salbutamol and fenoterol, but not of IL-4, was blocked in the presence of D,L-propranolol (1 microM) or butoxamine (1 microM). The alpha-adrenoceptor agonist, norepinephrine (1 microM), was ineffective in inducing CD23 expression or potentiating the one evoked by IL-4. Salbutamol down-regulated the expression of Fc gamma RI (CD64) and Fc gamma RII (CD32) whereas IL-4 was ineffective. Only when added together at the onset of the culture did salbutamol and IL-4 induce, after 48 hr, the expression of the monocyte marker, CD14. The expression of CD18 was up-regulated in response to salbutamol either alone or in combination with IL-4, this cytokine alone being inefficient. These data suggest that IL-4 and beta 2-adrenoceptor agonists induce differentiation of U 937 cells into monocyte-like cells.
Asunto(s)
Agonistas Adrenérgicos beta/farmacología , Antígenos CD/biosíntesis , Antígenos de Diferenciación Mielomonocítica/biosíntesis , Regulación de la Expresión Génica/efectos de los fármacos , Interleucina-4/farmacología , Monocitos/efectos de los fármacos , Receptores Adrenérgicos beta/fisiología , Receptores de IgE/biosíntesis , Albuterol/farmacología , Butoxamina/farmacología , Antígenos CD18 , Diferenciación Celular/efectos de los fármacos , Toxina del Cólera/farmacología , AMP Cíclico/biosíntesis , Sinergismo Farmacológico , Fenoterol/farmacología , Células Madre Hematopoyéticas/efectos de los fármacos , Células Madre Hematopoyéticas/metabolismo , Humanos , Receptores de Lipopolisacáridos , Monocitos/metabolismo , Norepinefrina/farmacología , Propranolol/farmacología , Receptores Adrenérgicos beta/efectos de los fármacos , Receptores de IgG/biosíntesis , Proteínas Recombinantes/farmacología , Sistemas de Mensajero Secundario , Células Tumorales CultivadasRESUMEN
The effect of a semi-synthetic cephalosporin, Cefadroxil, on antigen-induced bronchial hyperresponsiveness and eosinophil accumulation in lungs from sensitized guinea pigs was investigated and compared to the effects of Cetirizine and Ketotifen. When aerosol-sensitized guinea pigs were pretreated 1 h before the antigen challenge with Cefadroxil (100 mg/kg i.p.) a partial but significant inhibition of the bronchial hyperresponsiveness to aerosolized acetylcholine chloride was observed. Furthermore, the treatment of guinea pigs (115 mg/kg, per os) 24 and 1 h before ovalbumin challenge also significantly reduced bronchial hyperresponsiveness. In contrast, no significant inhibition was noted when the guinea pigs were treated by a single dose of Cefadroxil (115 mg/kg per os) 1 h before challenge. Pretreatment of the guinea pigs with Cetirizine (1 mg/kg per os) or Ketotifen (0.1 mg/kg per os) completely inhibited the antigen-induced bronchial hyperresponsiveness. Cefadroxil (100 mg/kg i.p.) slightly inhibited the accumulation of eosinophils in the peribronchial area induced by antigen challenge. In contrast, no significant reduction was noted when the guinea pigs were treated per os with Cefadroxil (115 mg/kg), Cetirizine (1 or 10 mg/kg) or Ketotifen (0.1 mg/kg). These results show that Cefadroxil is effective in reducing antigen-induced bronchial hyperresponsiveness, an effect independent of a reduction in the pulmonary inflammation, namely eosinophil accumulation in lung.
Asunto(s)
Hiperreactividad Bronquial/prevención & control , Cefadroxilo/farmacología , Eosinófilos/efectos de los fármacos , Pulmón/efectos de los fármacos , Acetilcolina , Aerosoles , Animales , Hiperreactividad Bronquial/inmunología , Cetirizina/farmacología , Eosinófilos/inmunología , Cobayas , Inmunización , Cetotifen/farmacología , Pulmón/inmunología , Ovalbúmina/inmunología , PremedicaciónRESUMEN
Lf presented differential effects in the induction of normal human monocyte activation. Lf inhibits the free radical generation by normal human monocytes in response to PMA. This effect on free radical generation is linked to the nature of the divalent cationic metal that substitutes the Apo-Lf. Indeed, the substitution of Fe2+ by another cationic transition metal (Cu2+, Zn2+, Pt2+ or Au2+) modifies the anti-oxidant effect of Lf. Among the different substituted Lf the Lf saturated with Cu2+ is the more potent inhibitor of free radical generation by normal human monocytes. In addition to its anti-oxidant effect, Lf stimulates, in combination with LPS, the production of cytokines (IL-1 beta, TNF-alpha and IL-6) and of prostacyclin (PGI2) by normal human monocytes. This potentiating effect is independent of the cation that substitutes the Lf, since the Apo-Lf is able to induce such a potentiating effect. In addition, whereas Lf does not modulate the phenotype of normal human monocytes stimulated or not with IL-4 it does enhance the IL-4-induced release of the soluble form of CD23 by these cells.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Antioxidantes , Lactoferrina/farmacología , Animales , Bovinos , Humanos , Lactoferrina/química , Mediciones Luminiscentes , Monocitos/efectos de los fármacos , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
The effect of platelet-activating factor (PAF) and of two specific PAF antagonists on tumor necrosis factor (TNF) induced superoxide production by human polymorphonuclear neutrophils (PMN) was examined. PAF alone (0.1 pM to 0.1 nM) failed to evoke superoxide production; however, when PAF was added for 10 min to cells upon prior incubation with 10 ng/mL TNF for 50 min, superoxide production was significantly enhanced as compared to that induced by TNF alone. Maximum amplification (+30%) was obtained with 10 pM PAF; however, the effect was completely abolished by two structurally unrelated PAF antagonists, BN 52021 and BN 52111. The antagonists also decreased by 25% the superoxide production elicited solely by TNF, implicating the involvement of endogenous PAF in this process. Pretreatment of the PMN with either pertussis or cholera toxin attenuated the PAF amplified superoxide production in TNF stimulated cells, suggesting that G proteins sensitive to these toxins may be involved in the mechanisms controlling amplification.
Asunto(s)
Diterpenos , Proteínas de Unión al GTP/fisiología , Neutrófilos/fisiología , Factor de Activación Plaquetaria/farmacología , Superóxidos/sangre , Factor de Necrosis Tumoral alfa/farmacología , Toxina del Cólera/farmacología , Dioxolanos/farmacología , Interacciones Farmacológicas , Ginkgólidos , Humanos , Técnicas In Vitro , Cinética , Lactonas/farmacología , Neutrófilos/efectos de los fármacos , Factor de Activación Plaquetaria/antagonistas & inhibidores , Compuestos de Piridinio/farmacología , Factores de Virulencia de Bordetella/farmacologíaRESUMEN
Granulocyte-macrophage CSF (GM-CSF) primes human neutrophils for increased functional responsiveness to a variety of inflammatory agonists. In the present report, we have investigated the effect of human GM-CSF on the ability of platelet-activating factor (PAF) to induce the synthesis of 5-lipoxygenase products in human neutrophils. Human neutrophils stimulated with PAF in the range of 10(-5) to 10(-7) M for 15 min released small quantities of leukotriene B4 and its omega-oxidation products, 20-OH- and 20-COOH-leukotriene B4 in amounts that were detectable by enzyme immunoassay. Preincubation of normal peripheral blood neutrophils with human rGM-CSF enhanced the synthesis of the 5-lipoxygenase products in a time- and dose-dependent manner. Treatment with GM-CSF enabled their detection in response to lower concentrations of PAF (greater than or equal to 10(-9) M). The PAF receptor antagonist BN52021 inhibited the synthesis of 5-lipoxygenase products by GM-CSF-treated neutrophils in response to PAF. In addition to its effect on PAF-induced leukotriene synthesis, GM-CSF also augmented intracellular calcium mobilization by PAF. This observation prompted us to examine the effect of GM-CSF on two calcium-dependent events that are essential for leukotriene synthesis, arachidonic acid liberation, and 5-lipoxygenase activation. GM-CSF by itself, did not directly activate either of these two processes, however, it consistently and markedly enhanced the ability of PAF to do so. These results indicate that preincubation of peripheral blood neutrophils with GM-CSF enhances the ability of PAF to stimulate leukotriene synthesis by increasing both arachidonic acid availability and 5-lipoxygenase activation in response to PAF. These observations provide additional evidence of an important role for GM-CSF in the modulation of inflammatory responses to endogenous agonists through enhancement of the production of potent cellular inflammatory mediators such as leukotrienes.
Asunto(s)
Diterpenos , Factor Estimulante de Colonias de Granulocitos y Macrófagos/fisiología , Leucotrieno B4/biosíntesis , Neutrófilos/metabolismo , Factor de Activación Plaquetaria/fisiología , Araquidonato 5-Lipooxigenasa/metabolismo , Ácido Araquidónico , Ácidos Araquidónicos/metabolismo , Cromatografía Líquida de Alta Presión , Activación Enzimática , Ginkgólidos , Humanos , Lactonas/farmacología , Neutrófilos/efectos de los fármacos , Neutrófilos/enzimología , Factor de Activación Plaquetaria/antagonistas & inhibidoresRESUMEN
Isolated hearts excised from normotensive (NT) and spontaneously hypertensive (SH) rats subjected to transient normothermic global ischemia were used to study the effect of chronic treatment with iloprost on reperfusion-induced arrhythmias and myocardial ion shifts. After 30 min of ischemia, iloprost given s.c. in doses of 10, 50, 100 and 200 micrograms/kg per day for 14 days reduced the incidence of reperfusion-induced ventricular fibrillation (VF) in isolated hearts from the control value of 91 to 83, 75, 50 (P less than 0.05) and 25% (P less than 0.01) respectively, in NT rats. In the SH groups, the incidence of VF was also reduced from 100 to 75, 58, 33 (P less than 0.01) and 17% (P less than 0.001), respectively, with 10, 50, 100 and 200 micrograms/kg per day of iloprost. A similar reduction was observed in the incidence of reperfusion-induced ventricular tachycardia (VT). Ischemia and reperfusion caused significant changes in myocardial ion contents, i.e. an increase in Na+ and Ca2+ and a decrease in K+ and Mg2+ concentrations. The myocardial water content was also increased in parallel to the Na+ gain. The effect of iloprost given s.c. in doses of 50 and 200 micrograms/kg per day for 14 days was also measured on myocardial ion contents after 15- or 30-min ischemia and 30-min ischemia plus 10-min reperfusion. The higher iloprost dose significantly reduced the myocardial Na+, Ca2+ and water gains and the loss of K+ induced by ischemia and reperfusion in the NT and SH groups, while the decrease in Mg2+ content was alleviated only in SH rats. The results suggest that long-term iloprost treatment reduces the incidence of reperfusion-induced VF and VT by preventing Na+, Ca2+ and water accumulation as well as K+ and Mg2+ loss from myocardial tissue.
Asunto(s)
Arritmias Cardíacas/prevención & control , Iloprost/farmacología , Daño por Reperfusión Miocárdica/tratamiento farmacológico , Miocardio/metabolismo , Animales , Arritmias Cardíacas/etiología , Cationes/metabolismo , Enfermedad Coronaria/tratamiento farmacológico , Enfermedad Coronaria/metabolismo , Técnicas In Vitro , Masculino , Daño por Reperfusión Miocárdica/complicaciones , Daño por Reperfusión Miocárdica/metabolismo , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Taquicardia/etiología , Taquicardia/prevención & control , Fibrilación Ventricular/etiología , Fibrilación Ventricular/prevención & controlRESUMEN
It has recently been demonstrated that very low concentrations of platelet-activating factor (PAF) and various cytokines can prime human neutrophils (PMN) to respond in an enhanced manner to subsequent agonistic stimulation. We were interested to ascertain whether superoxide generation by human PMN could be amplified by PAF following initial stimulation with tumor necrosis factor (TNF) and the effect of cholera and pertussis toxin on this process. PAF alone (0.1 pM-0.1 nM) failed to evoke any superoxide production; however, when PAF was added for 10 min to cells previously incubated for 50 min with 10 ng/ml TNF, superoxide production was significantly enhanced relative to that induced by TNF alone. Maximum amplification (+30%) was obtained with 10(-12) M PAF, this effect being completely abolished by BN 52021 and BN 52111, two structurally unrelated PAF antagonists. The PAF antagonists also decreased by 25% the superoxide production elicited solely by TNF, indicating that TNF-induced superoxide generation is partially mediated by a mechanism involving endogenous PAF. Pretreatment of the PMN with pertussis or cholera toxin reduced the amplification of superoxide production induced by PAF in TNF-stimulated PMN, implicating pertussis and cholera toxin-sensitive G-proteins in the amplification process.